Siris Medical, Inc was founded with the vision of improving treatment delivery and outcomes for patients undergoing radiation therapy for cancer treatment. Siris predictive software informs clinicians of treatment plan outcomes in real-time, enabling data-driven radiation oncology decision-making with Artificial Intelligence (AI). Siris Medical has two commercial products: QuickMatch and 510(k)-cleared PlanMD. These products leverage machine learning to connect each new patient to our growing market-leading oncology library of plan outcomes, with an opportunity to become the standard of care in treatment decision-making.